The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancer

Background The prognostic impact of tumour location (pancreatic head vs. pancreatic body/tail) and first-line chemotherapy regimen (gemcitabine plus nab-paclitaxel vs. modified FOLFIRINOX) has not been fully elucidated in locally advanced pancreatic cancer. Therefore, we conducted this study to examine the prognostic impact of tumour location and first-line chemotherapy regimen. Methods We retrospectively investigated locally advanced pancreatic...